| 9.6°C Dublin

New Covid-19 vaccine demonstrates ‘89% efficacy’


An experimental Covid-19 vaccine appears to offer strong protection in late-stage UK and South Africa studies, said manufacturer Novavax. The UK has secured access to 60 million doses of the vaccine, called NVX-CoV2373.

More Videos

Privacy